NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Overview of Management of Solid Tumors

December 14, 2018

Case managers and medical directors need to have wide-ranging knowledge about how solid tumors are managed so that they can help patients with solid tumors coordinate their care among different specialists (e.g., diagnostic radiology, medical oncology, palliative care). Understanding how all the aspects of solid tumor management fit together – from diagnosis and staging to multidisciplinary treatment to side effect management to survivorship or end-of-life care – can help case managers and medical directors strive for program quality improvements that help patients with cancer obtain the highest quality treatment possible and optimal cancer outcomes.

Target Audience

This program is designed to meet the educational needs of case managers, nurses in other roles (e.g., quality management and utilization review), medical directors at managed care organizations, reinsurers, TPAs, and case management and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care and/or make coverage decisions. Programs may also be of interest to nurses, nurse navigators/care coordinators, and physicians who work directly with patients in clinical settings as well as clinical pharmacists in managed care organizations and other settings.

Learning Objectives

Following this activity, participants should be able to:

  • Describe how solid tumors are diagnosed and staged.
  • Discuss the basic aspects of surgical management, radiation therapy, and systemic treatment of solid tumors.
  • Explain the importance of supportive care, survivorship care, and end-of-life care as part of optimal management for patients with solid tumors.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Astellas
  • AstraZeneca
  • Celgene Corporation
  • Ethicon
  • Novartis Pharmaceuticals
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Course summary
Available credit: 
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 CCM clock hours
  • 1.25 Participation
Course opens: 
10/16/2018
Course expires: 
02/10/2019
Event starts: 
12/14/2018 - 11:00am
Event ends: 
12/14/2018 - 12:15pm
Cost:
$0.00

Tara Sanft, MD
Yale Cancer Center/Smilow Cancer Hospital

Javin Brita, PA-C
Yale Cancer Center/Smilow Cancer Hospital

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 hours of Category 1 credit for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.25 contact hours.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 1.0 CE contact hour. Activity Code: I00034672; Approval #: 180004357

Pharmacists

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 1.25 contact hours (0.125 CEUs) of continuing education credit. UAN: 0836-0000-18-140-L01-P

Available Credit

  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 CCM clock hours
  • 1.25 Participation

Accreditation Period

Course opens: 
10/16/2018
Course expires: 
02/10/2019

Price

Cost:
$0.00
Please login or register to take this course.

Click the Take Course button to register for this upcoming live webinar.

This webinar will be presented live one time only on Friday, December 14, 2018, from 11:00 AM - 12:15 PM Eastern Standard Time (EST) (UTC -5).  To convert the start time of this webinar for other time zones, click here.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing